Why the study?
Does prophylactic ICD therapy reduce overall mortality in patients with acute myocardial infarction and clinical features that placed them at increased risk?
Does prophylactic ICD therapy reduce overall mortality in patients with acute myocardial infarction and clinical features that placed them at increased risk?
Prophylactic ICD therapy early after acute myocardial infarction does not reduce overall mortality in high-risk patients.
Early prophylactic ICDs were not associated with lower post-MI mortality; leaves open benefit in randomized trials of refined timing or subgroups.
Prophylactic ICD therapy did not reduce overall mortality among patients with acute myocardial infarction and clinical features that placed them at increased risk. (ClinicalTrials.gov number, NCT00157768.)
No takes yet. Share an insight, caveat, or question.
Steinbeck et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: